Ethics of Care and Ethics of Justice Essay Example | Topics and Well Written Essays - 2000 words

Ethics of Care and Ethics of Justice - Essay Example Thereupon, ethical prospects in nursing are at the core in this paper. Ethics of care seems to be taken for granted in nursing by many observers. It accompanies the idea of the Hippocratic Oath. Moreover, it makes the nurse-patient dialogue possible with emphasis on relief and recovery. However, this concept runs into the ethics of justice which can be narrowed down to a set of prescribed steps and norms in following nursing practice. Thus, the question of both ethical theories in their approaches toward contemporary medicine are to be duly analyzed so that to find out the best decision. ETHICS OF CARE Needless to say, current hospitals are full of professionals and those assisting them who can find out the right way in communication with patients. It is all about some psychological and moral obligations every nurse has at her/his disposal. The need for care is viewed to be paramount in hospitals. It makes the overall idea of recovery powerful. It goes without saying that a person can fight his/her illness starting from the inner decisions and inclinations. Believe it or not, such practice is well shared in the world. Moreover, it constitutes the need for care as a predominant impulse toward the inner recovery materializing in the physical healing. Ethics of care is well based on the personal relationships with a patient. It can be interpreted as the consideration of other’s point of view (Ashcroft, Dawson, & Draper, 2007). Care is a stimulus for every patient. Thus, a nurse able to follow up the prescriptions of her/his moral obligations before concrete patients, in particular, and the mankind, on the whole, has to use care every now and then. In other words, care is called to reduce patient’s vulnerability at the moment when it is critically high. Chesnay & Anderson (2011) admit in their study that ethics of care is generally focused on â€Å"attending to and meeting the needs of the particular others for whom we take responsibility† (p. 372). Thus, speaking ethically, the word â€Å"care† is already incorporated in the word â€Å"healthcare† justifying, therefore, the overall goal of the medicine. On the other hand, ethics of care seeks to pinpoint the need for relationship for the sake of striking a balance in gender roles. Definitely, women are more devoted to the caring; and the nursing ethics and ethics of care have become the pivotal virtues in the nursing practice far long ago (Yeo, 2010). To say more, ethical concerns should bear a confident character when applying to serious patients and those getting through some training and educational programs as a part of their recovery process (Klingberg-Allvin et al., 2007). Thus, the ethics of care is one of the first intentions coming on the part of a nurse despite of any circumstances or other impediments on her/his way. Again, relationship-based approach is what each nurse urges for. There is nothing more significant for a good and professionally fit nurse than to think about the need for assuring patients that they will be taken care of. To manage this prospect means to have an idea of where the nursing practice starts from: â€Å"The care ethics perspective cannot be understood in abstract or hypothetical terms, but only in actions stemming from caring relationships between people† (Sellman & Snelling, 2009, p. 60). Thus, any dispute on the nature of the ethics of care can be diminished due to a host of arguments on the importance of the first care aid and continuous care for patients throughout the period of hospitalization. Moreover, ethically grounded attitude of care on the part of a nurse is never a malfeasance. Ethics of justice Most researchers and observers are likely to state that ethics of justice serves a constraint for the

Synthes And Bioresorbable Internal Fixation Devices

Synthes And Bioresorbable Internal Fixation Devices Synthes roots are based in the non-profit Swiss research group, Association for the study of Internal Fixation or, AO, as it is referred to by the Swiss. The AO was formed by a group of medical professionals including orthopaedic surgeons, metallurgists and other scientists, whose goal was to find other means repairing complex fractures because the methods used around the time, the 1950s, was either left patients suffering months of rehabilitation or with permanent disabilities. AO was built around three basic principles research, education and development, the building blocks for any RD company. With regards to the education aspect of the organisation AO, would frequently offer multi-courses for other orthopaedic surgeons to enlighten them on the new internal fixation techniques. AO began to work with other non-profit organisations, distributing implants to a particular region in the world, with exclusive rights. Synthes was given exclusive rights to North America, and its counterparts Stratec and Mathys were given exclusive rights to Western Europe and Eastern Europe Asia and Africa respectively. Synthes Itself was split into four different companies, Orthopaedics, Spine, Maxillofacial and Canada. For the purpose of this report the main focus will be Synthes Orthopaedic; they are the leader in US orthopaedic trauma implant market with a domestic market share of approximately 50%. The question posed is whether or not Synthes should invest in bioresorbable devices, these are pins or screws or other fixation devices that degrade over time and are absorbed by the body instead of being removed manually. The obvious advantage is to the patients, because they will a smoother recovery process, the major problem that companies face however is finding the formula to maintain the fixation devices for a long enough period of time to ensure full recovery. One of the main reasons why Synthes should get into bioresorbable devices is the fact that they are a RD company and developing new products is their core function, it is one of the major values of the company. There is also the fact that any lapse in the RD of the company may lead to their competitors producing a like product, obtaining a patent and gaining market share and recognition at the expense of Synthes. With companies such as Johnson and Johnson and Boimet competing to achieve the same goal Synthes needs to always be one step ahead. In most cases it is best to be the first mover in an industry, for example when Phizer created the Viagra pill, albeit accidentally, they maintained a patent on the drug for several years and the exclusive production rights allowed them to corner the market. First movers sometimes even create an industry standard, such is the case for Microsoft. Many people still believe that Windows is the best and only operating system, even though there are m any other, much better OSs in the world. Furthermore Johnson Johnson have already crept ahead by producing the second generation of polymers for the industry, even though the success is still not as great as it could be, they still have that expertise. Synthes can use that knowledge to continue the research and possibly produce the third generation of polymers, the game changer, the one that works as well as they industry hopes. A key function that is required is not only research or develop the product, but also to sell it and another reason why Synthes should consider the bioresorbable market is because they have a hugely competent sales force, the case says they are the most experienced in the industry. There are reasons however why Synthes should not go in this market. Key among these is the fact that the market is growing very slowly and is still highly unstable according to the case. The research into stable polymers is going at a snails pace, it can be argued however that slow growth is better than no growth. Take the example of Apple who suffered in the shadows of Microsoft for many years, but one break with the launch of the iPod and the iPhone is helping to push them to the top of the technology market, their persistence paid off. The other main reason can be seen in the case of Johnson and Johnson in the case, although they were one of the first movers into the bioresorbable market, they failure of the product to perform on par with the metallic fixation devices has left them behind Synthes in that respect. 2Æ’Â   The four options discussed by the Synthes managers were to either ignore the bioresorbables completely while focusing on the improvement of their metallic implants or to wait-and-see, where-by they would monitor the progress of the other manufacturers and learn from them as they perform tests. During this stage Synthes will still invest heavily into the production of bioresorbables, that way they can quickly enter the market if they it started become a sounder means of income. The Third method was to develop and market their own line of bioresorbables with the current polymers on the market first developing plates and screws for hand, feet, wrists and ankle fractures and then they plan move to paediatric fractures. The final option is to continue research and development into the 3rd generation of bioresorbables implants, to improve the polymers in an effort to strengthen them and increase their reliability. The industry believes that progress can be made in the development of these polymers but is not quite sure exactly how much progress can actually be made. As with any corporate level decisions there are many advantages and or disadvantages connected. If Synthes chose to completely ignore the bioresorbables market their major advantage is that they will be able to focus more closely on their core competence, the development of metallic implants and improve it faster than their competitors as all of their focus will be on that aspect of the market. Ignoring the market completely is also a means of lowering the risks involved, because this is already their core function and because that sector of the market is far more stable than that of the bioresorbables market they are assured sustainable short term success. However this short term success is not conducive to growth. Synthes will, in effect, be limiting their growth prospects by not even attempting to develop their bioresorbables sector. As risky as it may be they if they were to take part and it became successful the rewards would heavily out-weigh the risks. They are in essence a research and development company and as previously mentioned RD is one of their core values, not even attempting to research the potential of bioresorbables would be undermining the nature of the company itself. Their scientists and researchers may potentially become frustrated if they are not allowed to even touch what to them could be the future of fracture repair. The second choice that Synthes managers discussed was to wait-and-see what the other manufactures are doing, letting the others do the main research and make the major mistakes, while Synthes learns from them and develops their own line of bioresorbables but doesnt market them until market conditions are favourable. In this method Synthes limits their risks significantly by not committing fully to either the development or marketing of their bioresorbables. They will only market if conditions are favourable, if conditions remain as unstable as they currently are then Synthes can simply pull out of the race. However the intend to invest $20 million into the development of their own bioresorbables; this is a very large and substantial investment. If it so happens that the market conditions remain unstable and Synthes decides not to go to market, they will incur a $20 million loss. They also face less risk in the development aspect because they will be leaving most of the work to their competitors; this also limits the amount of developmental failures they would incur if they were undertaking this task on their own. This may seem like the ideal choice for Synthes, however if their competitors do manage to develop more stable polymers and crack the secrets of bioresorbable internal fixation devices, then Synthes runs a patent blockage risk. If for example J J develop a perfectly functioning polymer and get their formula patented then they may have sole production rights for that particular formula for approximately 10 years. In those years they can create such a foothold in the market as the first movers that it could not only hinder the growth of Synthes, but in the worst case scenario, drive them out of the internal fixation device market completely. In the pharmaceutical industry, companies that have first mover advantage tend to retain that advantage for a very long period of time, as their products are more trusted than their competitors. The other drawback for Synthes is that even if a patent does not completely block them out of the industry, then they still run the risk of losing major m arket share to their many competitors. In the scenario where all of the competitors develop at the same pace and launch their products at the same time, the market pie will be divided among more players than is actually necessary thus limiting the potential market share for Synthes. The third option of developing and marketing their own bioresorbables is by far the most risky option that Synthes can take. However they may gain from the first-mover advantage mentioned above, they also have the ability to patent their formulas, block out competition and secure their place in the market for an extended period of time. This option also gives Synthes the opportunity to recuperate their investment into the development of their bioresorbables with the potential returns from marketing with the current polymers. These advantages however depend heavily on the success of the development phase. Therein lays the risk. If Synthes scientists and researchers get it wrong, the results could be disastrous for the company. The investment on development is $20 million, no mention was made of how much it would cost to actually market the product as well, this will push costs even higher, and to have a product fail with those additionally costs could be potentially fatal for Synthes. This is especially true for the paediatric fracture sector that Synthes is hoping to enter, failed products are bad enough, but failed products for children is almost irreversible damage for Synthes. No company wants to be branded as unsafe for children; something like this will lead to permanent scarring for Synthes. The final option of continued research and development into 3rd generation polymers, this once again is highly advantageous to Synthes as it returns them to their core competence of RD. This method will please their researchers and scientists greatly. It is a more balanced option because it is less risky than developing their bioresorbables with the current unstable polymers available and is far more proactive than ignoring the market completely or letting waiting for their competitors to do the research and testing. The costs involved however will be greater than most, if not all of the other methods, but the rewards if they get this one right will be even greater than all the previous methods put together. There are other downsides however, for example even though researchers and other scientists will be pleased to be working on ground breaking new technology, many failures will occur in the interim and this can lead to a large amount of frustration for them, which can be demotivat ing. Synthes still run the risk of their competitors developing better polymers before they do which would leave them in far greater debt than the other methods. The risks and benefits are great no matter what choice Synthes make, but the fact remains that they are essentially an RD company and should stick to their core competence of research development and education. They are industry leaders and need to maintain the high calibre performance they have been demonstrating over the years of their existence. Ignoring a new development, or waiting for their competitors to develop first should not even be an option for such a company. However at the same time jumping into developing and marketing an unstable product in an unstable market is very fool hardy and far too risky to undertake. Continuing to develop a new and safer means of internal fixation with bioresorbables is the best option for Synthes, the creation of the 3rd generation of polymers should be their priority. 3Æ’Â   In the debate of whether or not Synthes will have an impact on the bioresorbables industry, it is the opinion of the author that they can have a huge impact on the progress of the research and development aspect of the industry. Synthes have been a major player in the metallic fixation devices sector, they therefore have the knowledge on how the well the devices need to hold bones together, and also how they need to be shaped or designed to ensure maximum effectiveness. They are currently researching the effectiveness of the second generation polymers and can also begin to develop the third generation of polymers to catapult the industry into the future. The sheer size and capabilities of Synthes allow for them to exert a large amount of influence unto the market. 4Æ’Â   There are many ways for Synthes to introduce resorbables into the market. They are very innovative, with large amount of resources, capable management and therefore are capable of avoiding the valley of death where many innovations end up with poor management. Synthes can fund their own launch and therefore do not need the aid of venture capitalists as such. Great care needs to be used when introducing resorbables; and it is the belief of the author that Synthes should introduce their resorbables in the form of small screws or pins for smaller fractures and breaks first before they commit. This way they can be used on less complex injuries to test just how long they last, smaller fractures need less time to heal. If Synthes finds that their products are functioning properly then and only then, should they consider to manufacture for larger more complex injuries. This is far less risky but at the same time means that Synthes can still be proactive in their research and development. Use for small fractures only, not major complex broken bones. To ensure that they are stable enough and do no degrade in a short period of time. Merge to compete with other two heavyweights.

Love is Beautiful in Julius Caesar Essay -- Julius Caesar

The word love has thousands of meaning but in the end it can mean only one thing. Now over the years the word love had totally lost it’s meaning, but that’s not important to this essay. We are looking back at a time when love was a word that you didn’t throw around. When love still had meaning. When togas were still in style.   Ã‚  Ã‚  Ã‚  Ã‚  The word love is repeated in many forms throughout the play Julius Caesar. Unlike the way that we use it today, this word had different meanings. Someone saying it did not usually mean sexual feelings towards another, but it meant friendship in its own sick and twisted way. In all seriousness though, this word truly meant something back then. So that is what we’ll be looking at today, the multiple meanings of the word that is love. Grab your togas and join the fun!   Ã‚  Ã‚  Ã‚  Ã‚  Ok first we will be looking into act one. For those of you who didn’t read or just plain forgot what happened here it is in a nutshell. Ok Caesar just killed Pompay and is the over-all ruler of Rome. Some people do not like this and begin to conspire to kill Caesar. Easy enough, right? We see the word love many times in this act but lets check out the basics. Cassius says, â€Å"were I a common laughter or did use to stale with ordinary oaths my live to every new protestor† (line 73, Act I, scene II). What he is saying here is that he loves the people willing to protest the rule of Caesar. Now this isn’t â€Å"oh I love you marry me now† typ...

Ruth, the Bible

The Book Ruth by Ingunn Merete Borresen Ruth has 4 chapters. The first: Ruth  remains  loyal  to Naomi. The  second: Ruth gleans in Boaz’s field. The  third: Ruth follow Naomi’s plan. The fourth: Ruth and Boaz are married. The book of Ruth is the Narrative of a love story, yet also has some important Genealogy. The timeline of this book is intertwined during the period of the Judges. The author was anonymous but some believe it was perhaps written by Samuel the prophet; however, it is unlikely that he was alive when this book was written.It was written about 1046-1035 B. C. Key personalities include Ruth, Naomi, and Boaz. Its purpose was to demonstrate the kind of love, and faithfulness that God desires for us. It shows the difference between what happens when a nation does not follow in obedience to the covenant of God (Judges), and when God’s people follow in faithfulness within the covenant (Ruth). I was studying chapter 1 most, so I wrote little mor e on chapter 1 that I remember.Chapter 1: Elimelech was from Bethlehem in Judah, together with his wife and two sons he went to the country of Moab for living there for a while. His wife name was Naomi, and his two sons were Mahlon and Kilion. Elimelech died, and his sons got married to the Moabite women, named Orpah and Ruth. When they had lived there for around ten years, Mahlon and Kilion died and Naomi was left without her husband and two sons. Ruth and Orpah still were Naomi’s â€Å"daughters-in-law†. * In chapter 1, Ruth remains loyal to her mother-in-law Naomi after the death of her husband and in-laws.Naomi decides to return to her home land of Bethlehem alone, however, Ruth insists on staying with her and adopting Naomi’s God as her own. â€Å"But Ruth said, â€Å"Do not urge me to leave you or turn back from following you; for where you go, I will go, and where you lodge, I will lodge. Your people shall be my people, and your God, my God† (1:16 ). * Chapter 2 we see Ruth gleaning in the fields of Naomi’s relative Boaz. Boaz out of compassion and obedience to the law allows Ruth to glean but also leaves extra grain for her purposely. In chapter 3, Naomi encourages Ruth to seek marriage with Boaz as a kinsman-redeemer. Ruth obeys Naomi and asks for her rights and Boaz agrees but mentions that he must first be sure there are no others with first rights. * Chapter 4 Boaz and Ruth are married and Ruth conceives a son named Obed, the grandfather of the great King David, in the lineage of Christ our Messiah. Important characters in Ruth: Ruth: a young foreign widow who married a wealthy Israelite. She bore a son Obed, who was the grandfather of King David and an ancestor of Jesus of Nazareth.Naomi, her shrewd mother-in-law who advised her how to get a second husband, and was rewarded by the birth of a grandson. Boaz, the wealthy Israelite who married Ruth and became the father of Obed. FAMOUS QUOTES ‘where you go, I will go. Where you lodge, I will lodge. Your people shall be my people and your God my God. Where you die, I will die and there I will be buried. ’ (Ruth 1:16-17)Sources: http://www. readbibleonline. net/? page_id=15#top http://en. wikipedia. org/wiki/Book_of_Ruth

The Bahamas aspired to global leadership and recognition as a “Center of Excellence” in the delivery of services

The Bahamas aspired to global leadership and recognition as a â€Å"Center of Excellence† in the delivery of services. Excellence is not a skill it is an attitude. Explain what you think this means, providing examples. The Bahamas has aspired to global leadership and recognition as a center of excellence in the delivery of services. Aspirations of global leadership cannot be accomplished without excellence. In order to be a leader globally you need dedication, commitment and you need to be excellent in every aspect of your job. Since tourism is a major industry in the Bahamas, we have to be diverse and able to deliver the services we offer with class and pride. If we want a strong continuity of tourism we must provide the services that we have to the tourist with quality, distinction and superiority. For example, seeing as we provide beautiful beaches to our tourists, we cannot leave the beach unclean or polluted. We must keep the beaches clean so that more tourists would want to come back to our country. We also have to keep in mind that even though out country is very unique from other places, we are still in competition with them, if we don't provide exceptional services then our tourists will go to places that do provide exceptional services. How our delivery of services is received by the tourist will determine whether the tourism industry will have a major effect on our economy. Excellence can have a number of meanings, it can be defined as (1) the quality or state of being outstanding and superior or (2) a feature in which somebody or something is superior and outstanding or (3) something in which something or someone excels. In other words excellence can be said to be the state or quality of excelling. It is superiority, or the state of being good to a high degree. Excellence is considered to be a value by many organizations, in particular by schools and other institutions of education, and a goal to be pursued. The pursuit of excellence is not to be a quest for superiority, and is not about competition, which is usually done for one's own glory or significance or for the praise or applause of men. Excellence means being your best,being better tomorrow than you were yesterday and matching your practice with your potential. It can be said that excellence is not a skill but an attitude bcause a skill is an ability, usually learned and acquired through training, to perform actions and an attitude is a personal view of something, an opinion or general feeling about something. Excellence cannot be learned or acquired through training. A parent or teacher cannot teach a child to be excellent; he or she can only teach that child to have an attitude of excellency or to have a positive mindset of being excellent. If someone has a strong personal view of being excellent then that person has a greater chance of succeeding in that endeavor. There is a greater chance of experiencing Excellency because if you have a positive outlook on life and you believe that excellence is an attitude that starts on the inside you will never fail. Everything starts out as a seed that grows from the inside. Excellency is the attitude that starts on the inside of a person.